Kazia Therapeutics Limited (KZIA)

USD 2.85

(-16.18%)

Annual Income Statements

(In AUD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 2.3 Million 555.00 25.00 15.18 Million 1061.00 1565.00
Cost of Revenue - - - - - -
Gross Profit 2.3 Million 555.00 25.00 15.18 Million 1061.00 1565.00
Operating Expenses 2.3 Million 24.12 Million 24.88 Million 24.13 Million 13.16 Million 10.25 Million
Selling, General and Administrative Expenses 13.56 Million 8.58 Million 4.63 Million 7.02 Million 3.69 Million 3.78 Million
Research and Development Expenses 17.38 Million 15.56 Million 20.25 Million 14.54 Million 9.49 Million 6.47 Million
Other Expenses -28.63 Million -22.55 Thousand -10 Thousand - -22 Thousand -9000.00
Cost and Expenses 2.3 Million 24.12 Million 24.88 Million 24.13 Million 13.16 Million 10.25 Million
Operating Income - -24.12 Million -26.69 Million -6.37 Million -12.52 Million -8.38 Million
Interest Expense - - 2094.00 - - 2.18 Million
Income Tax Expense -271 Thousand 271.09 Thousand -368.08 Thousand 484.34 Thousand -298 Thousand -298 Thousand
Earnings before Tax -27.04 Million -20.73 Million -25.01 Million -8.9 Million -12.76 Million -10.56 Million
Net Income -26.77 Million -20.46 Million -24.64 Million -8.42 Million -12.46 Million -10.27 Million
Earnings Per Share Basic - -1.12 -1.86 -0.07 -1.71 -1.79
Earnings Per Share Diluted - -1.11 -1.86 -0.07 -1.71 -1.79
Weighted Average Shares Outstanding - 18.22 Million 13.24 Million 117.62 Million 7.3 Million 5.75 Million
Weighted Average Shares Outstanding (Diluted) - 18.42 Million 13.24 Million 117.67 Million 7.3 Million 5.75 Million
Gross Margin 1.00 1.00 1.00 1.00 1.00 1.00
EBIT Margin -11.60 -40.13 Thousand -989.73 Thousand -0.34 -10.78 Thousand -4661.98
Profit Margin -11.60 -36.87 Thousand -985.91 Thousand -0.55 -11.75 Thousand -6562.30
EBITDA -26.76 Million -22.27 Million -23.51 Million -5.11 Million -11.1 Million -7.71 Million
Earnings Before Tax Margin - -43.46 Thousand -1.06 Million -0.42 -11.8 Thousand -5354.63

Income Statement Charts